Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hartge

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Journal of the National Cancer Institute|May 1, 1996
Importance of alpha-carotene, beta-carotene, and other phytochemicals in the etiology of lung cancerR G Ziegler, E A Colavito, P Hartge, et al.
Journal of the National Cancer Institute|July 5, 1995
Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidenceF R Cleghorn, A Manns, R Falk, et al.
JAMA|May 14, 1997
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanomaM A Tucker, A Halpern, E A Holly, et al.
Lancet (London, England)|November 5, 1998
Population-based study of risk of breast cancer in carriers of BRCA2 mutationS Thorlacius, J P Struewing, P Hartge, et al.
Journal of the National Cancer Institute|June 1, 1987
Changing cigarette habits and bladder cancer risk: a case-control studyP Hartge, D Silverman, R Hoover, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variationP Hartge, E A Holly, A Halpern, et al.
Bulletin of the Pan American Health Organization|January 1, 1993
Determinants of the geographic variation of invasive cervical cancer in Costa RicaR Herrero, L A Brinton, P Hartge, et al.
Lancet (London, England)|December 11, 1993
Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study GroupA Manns, F R Cleghorn, R T Falk, et al.
The New England Journal of Medicine|May 15, 1997
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsJ P Struewing, P Hartge, S Wacholder, et al.
Nature Genetics|September 10, 1998
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi JewsT Woodage, S M King, S Wacholder, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|May 1, 1996
Importance of alpha-carotene, beta-carotene, and other phytochemicals in the etiology of lung cancerR G Ziegler, E A Colavito, P Hartge, et al.
Journal of the National Cancer Institute|July 5, 1995
Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidenceF R Cleghorn, A Manns, R Falk, et al.
JAMA|May 14, 1997
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanomaM A Tucker, A Halpern, E A Holly, et al.
Lancet (London, England)|November 5, 1998
Population-based study of risk of breast cancer in carriers of BRCA2 mutationS Thorlacius, J P Struewing, P Hartge, et al.
Journal of the National Cancer Institute|June 1, 1987
Changing cigarette habits and bladder cancer risk: a case-control studyP Hartge, D Silverman, R Hoover, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variationP Hartge, E A Holly, A Halpern, et al.
Bulletin of the Pan American Health Organization|January 1, 1993
Determinants of the geographic variation of invasive cervical cancer in Costa RicaR Herrero, L A Brinton, P Hartge, et al.
Lancet (London, England)|December 11, 1993
Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study GroupA Manns, F R Cleghorn, R T Falk, et al.
The New England Journal of Medicine|May 15, 1997
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsJ P Struewing, P Hartge, S Wacholder, et al.
Nature Genetics|September 10, 1998
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi JewsT Woodage, S M King, S Wacholder, et al.
Pageof 10